People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Climate / Cleantech, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ChargePoint, Inc. | — | Climate / Cleantech | Series D+ | $570.9M | $3.1B | 2009 |
| ARS Pharmaceuticals, Inc. | — | Pharmaceuticals | Series C | $63.0M | $1.3B | 2018 |
Richard Lowenthal at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard Lowenthal on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Leff | 1 | 11 |
| Mark Leschly | 1 | 9 |
| Jeffrey Harris | 1 | 9 |
| Peter Kolchinsky | 1 | 8 |
| Rajeev Dadoo | 1 | 7 |
| Pratik Shah | 1 | 5 |
| Michael Linse | 1 | 5 |
| Brent Saunders | 1 | 5 |
| Bruce Chizen | 1 | 4 |
| Daniel Ahn | 1 | 4 |
| Jonathan Kaplan | 1 | 4 |
| Neil Suslak | 1 | 2 |
| William Thayer | 1 | 2 |
| Dana McGowan | 1 | 2 |
| Pasquale Romano | 1 | 1 |
| Antonio Canova | 1 | 1 |
| Praveen Mandal | 1 | 1 |
| Dave Baxter | 1 | 1 |
| Mike Kelly | 1 | 1 |
| Wagoner Richard | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.